This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by BRAILLY, S. Articles by PAPIERNIK, E. Search for Related Content PubMed PubMed Citation Articles by BRAILLY, S. Articles by PAPIERNIK, E.

Androgens and Progestins in the Human Ovarian Follicle: Differences in the Evolution of Preovulatory, Healthy Nonovulatory, and Atretic Follicles^*

Groupe de Recherches sur la Biochimie Endocrinienne et la Reproduction (INSERM U. 135), Faculté de Medecine de Bicêtre, Universite de Paris-Sud 94270 Kremlin-Bicêtre France
the Physiologie et Psychologie de la Reproduction Humaine, INSERM U. 187 France
the Service de Gynecologie-obstétrique, Hôpital Antoine Beclère (E.P.), 92140 Clamart France

Address requests for reprints to: Dr. E. Milgrom, Hopital de Bicetre, 94270 Le Kremlin-Bicetre, France.

Morphological and histoenzymological criteria allowed classification of large human ovarian follicles into three categories: preovulatory, healthy nonovulatory, and atretic. Follicular fluid steroids were measured in each type of follicle during various phases of the follicular portion of the menstrual cycle.

Androstenedione was the principal follicular fluid androgen in all categories. Testosterone and dihydrotestosterone concentrations were, respectively, 7–9÷ and 0.4–0.8÷ that of androstenedione. Androgen concentrations were very low in preovulatory follicles. They showed a further 3-fold decrease between phase I (from the beginning of the estrogen surge to the estrogen peak) and phase III (from the LH surge to ovulation). Atretic follicles had very high concentrations of androgens. Healthy nonovulatory follicles showed intermediate levels which increased progressively during the follicular phase until the onset of atresia.

Progesterone and 17-hydroxyprogesterone were present in concentrations of similar magnitude in all follicles except phase III preovulatory, in which progesterone was 4 times more abundant than 17-hydroxyprogesterone. Preovulatory follicles at all phases showed higher progestin concentrations than follicles of other categories.

The use of the androstenedione to 17-hydroxyprogesterone and estradiol to androstenedione ratios to tentatively evaluate the efficiency of androgen and estrogen formation allowed further characterization of the three categories. Healthy nonovulatory follicles showed an average efficiency of both reactions, with an increase in the androstenedione to 17-hydroxyprogesterone ratio and a decrease in the estradiol to androstenedione ratio during the periovulatory period. Atretic follicles exhibited a highly efficient transformation of progestin into androgen but a very low aromatization potency. The preovulatory follicle was characterized by a highly efficient aromatization and a very inefficient transformation of progestin into androgen. At phase III, the estradiol to androstenedione ratio was twice that at phase I, whereas the androstenedione to 17-hydroxyprogesterone ratio showed a dramatic 8-fold decrease. These results suggest that the shift of the preovulatory follicle from estrogen to progestin accumulation during phase III is due to a further decrease in the transformation of progestins into androgens and not to a decreased efficiency of aromatization. It must, however, be emphasized that these conclusions were based on determinations of hormone levels in the follicles and not on actual measurements of steroid conversions.

^* This work was supported by the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, and the Fondation pour la Recherche Medicale Francaise.

Received November 18, 1980.

This article has been cited by other articles:

				M. M. Kushnir, T. Naessen, D. Kirilovas, A. Chaika, J. Nosenko, I. Mogilevkina, A. L. Rockwood, K. Carlstrom, and J. Bergquist Steroid Profiles in Ovarian Follicular Fluid from Regularly Menstruating Women and Women after Ovarian Stimulation Clin. Chem., March 1, 2009; 55(3): 519 - 526. [Abstract] [Full Text] [PDF]

				M. R. Sowers, H. Zheng, D. McConnell, B. Nan, S. D. Harlow, and J. F. Randolph Jr. Estradiol Rates of Change in Relation to the Final Menstrual Period in a Population-Based Cohort of Women J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3847 - 3852. [Abstract] [Full Text] [PDF]

				C.K. Welt, Y. Jimenez, P.M. Sluss, P.C. Smith, and J.E. Hall Control of estradiol secretion in reproductive ageing Hum. Reprod., August 1, 2006; 21(8): 2189 - 2193. [Abstract] [Full Text] [PDF]

				C. C. W. Chan, E. H. Y. Ng, O. S. Tang, W. S. B. Yeung, E. Y. L. Lau, and P. C. Ho A Prospective, Randomized, Double-Blind Study to Compare Two Doses of Recombinant Human Chorionic Gonadotropin in Inducing Final Oocyte Maturity and the Hormonal Profile during the Luteal Phase J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3933 - 3938. [Abstract] [Full Text] [PDF]

				A. J. Jakimiuk, S. R. Weitsman, H.-W. Yen, M. Bogusiewicz, and D. A. Magoffin Estrogen Receptor {alpha} and {beta} Expression in Theca and Granulosa Cells from Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5532 - 5538. [Abstract] [Full Text] [PDF]

				B. LINDENTHAL, A. L. HOLLERAN, T. A. ALDAGHLAS, B. RUAN, G. J. SCHROEPFER Jr, W. K. WILSON, and J. K. KELLEHER Progestins block cholesterol synthesis to produce meiosis-activating sterols FASEB J, March 1, 2001; 15(3): 775 - 784. [Abstract] [Full Text] [PDF]

				M.P. Teissier, H. Chable, S. Paulhac, and Y. Aubard Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability Hum. Reprod., December 1, 2000; 15(12): 2471 - 2477. [Abstract] [Full Text] [PDF]

				A. L. Schneyer, T. Fujiwara, J. Fox, C. K. Welt, J. Adams, G. M. Messerlian, and A. E. Taylor Dynamic Changes in the Intrafollicular Inhibin/Activin/Follistatin Axis during Human Follicular Development: Relationship to Circulating Hormone Concentrations J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3319 - 3330. [Abstract] [Full Text]

				G.L. Driscoll, J.P.P. Tyler, J.T. Hangan, P.R. Fisher, M.A. Birdsall, and D.C. Knight A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation Hum. Reprod., June 1, 2000; 15(6): 1305 - 1310. [Abstract] [Full Text] [PDF]

				A. J. Jakimiuk, S. R. Weitsman, and D. A. Magoffin 5{alpha}-Reductase Activity in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2414 - 2418. [Abstract] [Full Text]

				C. Mendoza, N. Cremades, E. Ruiz-Requena, F. Martinez, E. Ortega, S. Bernabeu, and J. Tesarik Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations Hum. Reprod., March 1, 1999; 14(3): 628 - 635. [Abstract] [Full Text] [PDF]

				V. Machelon, F. Nomé, and J. Tesarik Nongenomic Effects of Androstenedione on Human Granulosa Luteinizing Cells J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 263 - 269. [Abstract] [Full Text]

				B. C. J. M. Fauser and A. M. van Heusden Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences Endocr. Rev., February 1, 1997; 18(1): 71 - 106. [Abstract] [Full Text]